课题基金 / 基金详情

RATIONAL DESIGN OF ANTISICKLING AGENTS

RATIONAL DESIGN OF ANTISICKLING AGENTS
抗镰剂的合理设计
批准号:
6526574
负责人:
Martin K Safo
金额:
$9.02万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-09-01 至 2005-08-31

项目摘要

项目成果

Martin K Safo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (Adapted from applicant's abstract) The applicant's career goal is to seek a research position in a reputable Institution. His primary goal would be to establish rigorous research programs involving structure-based drug design to find the origin, causes, treatment and prevention of tropical diseases, such as sickle cell anemia, malaria, and sleeping sickness. Furthermore, it is anticipated that molecular modeling techniques unique to the problems to be encountered will be developed to improve the efficiency of the drug development process. To reach these goals, would require considerable experience and skills in drug designing process. Therefore, under the direction of his mentor, he intends to initiate a career development research program involving rational development of compounds to treat sickle cell anemia. This would help him gain the necessary skills and experience to develop his career as an independent researcher. Below is a brief description of the proposal research. A group of halogenated aromatic compounds are known to bind to hemoglobin and show potential as antisickling agents. These compounds bind to the surface of the protein and may explain the antisickling properties. The long term-goal of this research project is to utilize the above information to design and develop stereospecific agents to bind with high affinity to the surface of the hemoglobin for more potent antisickling agents. In addition, both the T and R-state hemoglobins will be used to study structure-function activities. Therefore, the specific aims are: 1) determine and refine the crystal structures of the deoxygenated hemoglobin co-crystallized with halogenated aromatic acids; 2) determine and refine the crystal structures of carbonmonoxy hemoglobin bound with halogenated aromatic acid; 3) rational design of new stereospecific compounds to bind to known binding sites at the surface of the hemoglobin, and other newly identified binding sites; and 4) biological evaluation of the designed compounds for antisickling, antigelling and allosteric activities.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
Structures of R- and T-state hemoglobin Bassett: elucidating the structural basis for the low oxygen affinity of a mutant hemoglobin.
R 态和 T 态血红蛋白的结构 Bassett:阐明突变血红蛋白的低氧亲和力的结构基础。
DOI: 10.1107/s0907444904030501
发表时间: 2005
期刊: Acta crystallographica. Section D, Biological crystallography
影响因子: --
作者: [Safo,MartinK, Abdulmalik,Osheiza, Lin,HsiangRu, Asakura,Toshio, Abraham,DonaldJ]
通讯作者: Abraham,DonaldJ
Structure of cytomegalovirus nuclease, UL98
  • 批准号:
    8969474
  • 项目类别:
  • 资助金额:
    $7.63万
  • 财政年份:
    2015
  • 负责人:
    Martin K Safo
  • 依托单位:
Structure of cytomegalovirus nuclease, UL98
  • 批准号:
    9086246
  • 项目类别:
  • 资助金额:
    $7.63万
  • 财政年份:
    2015
  • 负责人:
    Martin K Safo
  • 依托单位:
Hemoglobin Modifiers for Sickle Cell Disease Therapy
  • 批准号:
    8776137
  • 项目类别:
  • 资助金额:
    $40.9万
  • 财政年份:
    2014
  • 负责人:
    Martin K Safo
  • 依托单位:
Hemoglobin Modifiers for Sickle Cell Disease Therapy
  • 批准号:
    9250636
  • 项目类别:
  • 资助金额:
    $39.59万
  • 财政年份:
    2014
  • 负责人:
    Martin K Safo
  • 依托单位:
海外基金